ACACA and psoriasis: We have recently demonstrated that the genetic ablation of ACC1 in T cells ameliorates skin inflammation in an experimental model of psoriasis by restraining the T cell effector immune response in skin lesions and increasing the frequency of effector Tregs in skin-draining lymph nodes (LNs) [56].